Clinical Trials Logo

Clinical Trial Summary

Sugammadex is new drug that is used for reversal of rocuronium induced muscle relaxation. benefits of reversal of neuromuscular blockade appears to be of great value in living donor liver transplant recipients. However, Few Clinical reports have investigated the anticoagulant effect of sugammadex. In this study, effects of sugammadex on bleeding profile of living donor liver transplantation will be investigated.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02939430
Study type Interventional
Source Mansoura University
Contact
Status Recruiting
Phase N/A
Start date November 2016
Completion date November 2017